Metabolic profiling of PPARα −/− mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator‐activated receptor‐α (PPARα) is a master transcriptional regulator of β‐oxidation and a prominent target of hypolipidemic drugs. To gain deeper insights into the systemic consequences of impaired fat catabolism we used quantitative, mass spectrometry‐based metabolic profiling to investigate the fed‐to‐fasted transition in PPARα +/+ and PPARα −/− mice. Compared to PPARα +/+ animals' acylcarnitine profiles of PPARα −/− mice revealed 2‐ to 4‐fold accumulation of long‐chain species in the plasma' whereas short‐chain species were reduced by as much as 69% in plasma, liver, and skeletal muscle. These results reflect a metabolic bottleneck downstream of carnitine palmitoyltransferase‐1, a mitochondrial enzyme that catalyzes the first step in β‐oxidation. Organic and amino acid profiles of starved PPARα −/− mice suggested compromised citric acid cycle fluX, enhanced urea cycle activity, and increased amino acid catabolism. PPARα −/− mice had 40‐50% lower plasma and tissue levels of free carnitine, corresponding with diminished hepatic expression of genes involved in carnitine biosynthesis and transport. One week of oral carnitine supplementation conferred partial metabolic recovery in the PPARα −/− mice. In summary, comprehensive metabolic profiling revealed novel biomarkers of defective fat oxidation, while also highlighting the potential value of supplemental carnitine as a therapy and diagnostic tool for metabolic disorders.—Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Muoio, D. M. Metabolic profiling of PPARα −/− mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23, 586‐604 (2009)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies in PPAR␣ null mice confirmed an essential role for this nuclear receptor in regulating carnitine homeostasis, because these animals have a profound systemic carnitine deficiency associated with reduced hepatic expression of OCTN2 and ␥-butyrobetaine hydrox-ylase-1 (35,36).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [36]
Citations
Cites
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · cited 2×
“increase -oxidation in the postabsorptive state (6).”
MethodSelf-citationCahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,319
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Tanaka, M., Yamamoto, Y., Misawa, E., Nabeshima, K., Saito, M., Yamauchi, K., Abe, F., & Furukawa, F. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000454718 · Cited by 1,092
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Hypoxia-Inducible Factor 1 (HIF-1) Pathway
Semenza, G. L. (2007) · Science's STKE · doi:10.1126/stke.4072007cm8 · Cited by 945 · cited 1×
“An intriguing candidate for such signal is -ketoglutarate, a critical metabolic intermediate that also plays a role in stress response via its regulation of the hypoxia-inducible factors (HIF) 1 and 2 (33, 34).”
BackgroundLeone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Research works printed but not linked: 1
- 10.1042/bj3610417 · DOI · Paper page
Cited by
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
“Amino Acid metabolism ABAT [24, 159], Acmsd [159], AGXT2 [24, 160], Arg1 [160], ASL [24, 160], Ass1 [160], CBS [24, 159], CPS-1 [24, 160], Cth [159], Got1 [160], Got2 [62, 64, 160, 161], Gls [160], GLS2 [159], GPT [24, 159], Hal [159], Hpd [159], OAT [24, 159], ODC1 [24, 62, 159], OTC [24, 62, 160], PAH [24, 159], PSA…”
BackgroundIntegrated physiology and systems biology of PPARα
Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.002 · Cited by 670
“Furthermore, plasma levels of long chain acyl-carnitines are increased in fasted PPARa / mice, whereas plasma levels of medium and short chain acyl-carnitines and free carnitine are decreased, reflecting impaired fatty acid oxidation (Table 1) [21,27].”
BackgroundInfluentialBedi, K. C., Snyder, N. W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A. J., Wang, L. L., Javaheri, A., Blair, I. A., Margulies, K. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017545 · Cited by 650
The inflammation highway: metabolism accelerates inflammatory traffic in obesity
Johnson, A. R., Justin Milner, J., & Makowski, L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01151.x · Cited by 603
Self-citationEllis, J. M., Li, L. O., Wu, P.-C., Koves, T. R., Ilkayeva, O., Stevens, R. D., Watkins, S. M., Muoio, D. M., & Coleman, R. A. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.012 · Cited by 357
“Long-chain acyl-carnitines accumulate when their production by mitochondrial CPT1 exceeds their flux through b-oxidation (Makowski et al., 2009).”
Self-citationMetabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 328
“More recently, targeted GC-MS and LC-MS-MS analysis has provided deeper insights by showing that PPAR- knockout results in fasting hypoglycemia accompanied by depletion of TCA cycle intermediates and free carnitine and short-chain acylcarnitines, as well as accumulation of long-chain acyl CoAs in skeletal muscle (58).”
BackgroundSelf-citationNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Self-citationPPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
Contreras, A. V., Torres, N., & Tovar, A. R. (2013) · Advances in Nutrition · doi:10.3945/an.113.003798 · Cited by 236
“The amino acids linked to the urea cycle, which include aspartate, arginine, and citrulline, are increased in PPAR-a knockout mice compared with wild-type mice (59).”
BackgroundMetabolomics in Toxicology: Preclinical and Clinical Applications
Robertson, D. G., Watkins, P. B., & Reily, M. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq358 · Cited by 211
Chen, S., Hoene, M., Li, J., Li, Y., Zhao, X., Häring, H.-U., Schleicher, E. D., Weigert, C., Xu, G., & Lehmann, R. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.05.019 · Cited by 217
Ellis, J. M., Mentock, S. M., DePetrillo, M. A., Koves, T. R., Sen, S., Watkins, S. M., Muoio, D. M., Cline, G. W., Taegtmeyer, H., Shulman, G. I., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01085-10 · Cited by 194
“Cellular acyl-carnitines are markers of metabolite flux through degradative and oxidative pathways (30).”
BackgroundSelf-citationHenagan, T. M., Stefanska, B., Fang, Z., Navard, A. M., Ye, J., Lenard, N. R., & Devarshi, P. P. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13058 · Cited by 171
“Acylcarnitines are formed from the addition of a carnitine to an intermediate of fatty acid oxidation, and measurement of the various acylcarnitines is a reflection of the completeness of β-oxidation (Koves et al., 2008; Makowski et al., 2009; Henagan et al., 2014).”
BackgroundMethodThe Role of PPARαActivation in Liver and Muscle
Burri, L., Thoresen, G. H., & Berge, R. K. (2010) · PPAR Research · doi:10.1155/2010/542359 · Cited by 159
Todisco, S., Santarsiero, A., Convertini, P., Stefano, G. D., Gilio, M., Iacobazzi, V., & Infantino, V. (2022) · Biology · doi:10.3390/biology11050792 · Cited by 181
Zhou, L., Wang, Q., Yin, P., Xing, W., Wu, Z., Chen, S., Lu, X., Zhang, Y., Lin, X., & Xu, G. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5782-4 · Cited by 171
Self-citationDyar, K. A., Hubert, M. J., Mir, A. A., Ciciliot, S., Lutter, D., Greulich, F., Quagliarini, F., Kleinert, M., Fischer, K., Eichmann, T. O., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2005886 · Cited by 153
Carnitine, mitochondrial function and therapy
Zammit, V. A., Ramsay, R. R., Bonomini, M., & Arduini, A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.024 · Cited by 149
Liu, Y., Hong, Z., Tan, G., Dong, X. W., Yang, G., Zhao, L., Chen, X., Zhu, Z., Lou, Z., Qian, B., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28706 · Cited by 141
“A similar trend of acylcarnitines levels in HCC patients was also observed in a recent study.(41) It is known that acylcarnitines play a decisive role in free fatty acid oxidation, responsible for the transportation of acyl-coenzyme A into mitochondria.”
ResultSampey, B. P., Freemerman, A. J., Zhang, J., Kuan, P.-F., Galanko, J. A., O'Connell, T. M., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Newgard, C. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038812 · Cited by 136
“Recent work has demonstrated that metabolomic analysis can provide a view of mitochondrial function that reflects the physiologic or pathophysiologic state of the system [26,27,36,56].”
BackgroundMethodSelf-citationPooya, S., Blaise, S. A., Garcia, M. M., Giudicelli, J., Alberto, J., Guéant‐Rodriguez, R., Jeannesson, É., Guéguen, N., Bressenot, A., Nicolas, B., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.028 · Cited by 149
“The PPAR-a/PGC1a pathway plays a key role in the gene expression of OCTN transporters [37,38].”
BackgroundCeccarelli, S. M., Chomienne, O., Gubler, M., & Arduini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100809g · Cited by 119
Ren, X., Geng, N., Zhang, H., Wang, F., Gong, Y., Song, X., Luo, Y., Zhang, B., & Chen, J. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.388 · Cited by 105
Carnitine Acetyltransferase Mitigates Metabolic Inertia and Muscle Fatigue during Exercise
Seiler, S. E., Koves, T. R., Gooding, J. R., Wong, K. E., Stevens, R. D., Ilkayeva, O. R., Wittmann, A. H., DeBalsi, K. L., Davies, M. N., Lindeboom, L., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.003 · Cited by 105
“Consistent with previous reports (Makowski et al., 2009; Noland et al., 2009), administration of L-carnitine in the drinking water for 2 weeks increased resting blood levels of free carnitine and acetylcarnitine by 30% and 20%, respectively, regardless of genotype (Figures 5A and 5B).”
Self-citationMechanisms of hepatic fatty acid oxidation and ketogenesis during fasting
Ruppert, P. M. M., & Kersten, S. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.10.002 · Cited by 110
Measuring mitochondrial respiration in intact single muscle fibers
Schuh, R. A., Jackson, K. C., Khairallah, R. J., Ward, C. W., & Spangenburg, E. E. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00229.2011 · Cited by 90
Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion
White, P. J., Lapworth, A. L., McGarrah, R. W., Kwee, L. C., Crown, S. B., Ilkayeva, O., An, J., Carson, M. W., Christopher, B. A., Ball, J. R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108375 · Cited by 85
“…would improve glucose and lipid handling in HF fed ZFRs by preventing accumulation of fatty acid metabolites, analogous to the salutary effects of carnitine supplementation or BCAA restriction in obesity models (Makowski et al., 2009; Muoio et al., 2012; Noland et al., 2009; White et al., 2016).”
BackgroundSelf-citationHenagan, T. M., Lenard, N. R., Gettys, T. W., & Stewart, L. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089365 · Cited by 71
“This finding is reinforced by the lack of positive correlations observed by 8wks in HF and HF+600Q, in which PGC1a levels are similar to in HF and decreased in HF+600Q compared to 3wk PGC1a values and where incomplete beta oxidation is apparent via pairwise correlation matrices [4,37,39,40].”
Anderson, K. A., Lin, F., Ribar, T. J., Stevens, R. D., Muehlbauer, M. J., Newgard, C. B., & Means, A. R. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1299 · Cited by 75
“The acylcarnitine profile has been shown to reflect the state of fat oxidation in liver as demonstrated in PPAR / mice where fat oxidation is blocked, or by WT mice as they transition from the fed to the fasted state (23, 42).”
BackgroundSelf-citationIwaki, T., Bennion, B. G., Stenson, E. K., Lynn, J. C., Otinga, C., Djukovic, D., Raftery, D., Fei, L., Wong, H. R., Liles, W. C., et al. (2019) · Physiological Reports · doi:10.14814/phy2.14078 · Cited by 77
“This indicates a higher degree of protein turn over in Ppara / mice, which is consistent with previous findings demonstrating that PPARa activation suppresses amino acid metabolism and attendant urea cycle function (Tremblay and Qureshi 1993; Feoli-Fonseca et al. 1996; Kersten et al. 2001; Makowski et al. 2009; Brosna…”
Chandran, K., Goswami, S., & Sharma-Walia, N. (2015) · Oncotarget · doi:10.18632/oncotarget.6402 · Cited by 74
“Profiles of PPARα −/− mice have been reported to reveal defects in energy regulation, fatty acid catabolism and carnitine homeostasis [43, 44].”
BackgroundPatel, M. J., Batch, B. C., Svetkey, L. P., Bain, J. R., Turer, C. B., Haynes, C. S., Muehlbauer, M. J., Stevens, R. D., Newgard, C. B., & Shah, S. H. (2013) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0031 · Cited by 70
“…in both animal models and humans (Kien et al., 2011; Koves et al., 2008), and interventions that lower the levels of these metabolites, such as exercise or carnitine supplementation, simultaneously improve insulin sensitivity (Koves et al., 2005; Makowski et al., 2009; Noland et al., 2009).”
Self-citationPPARs and the orchestration of metabolic fuel selection
Sugden, M. C., Zariwala, M. G., & Holness, M. J. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.014 · Cited by 64
Lustgarten, M. S., Price, L. L., Chalé, A., & Fielding, R. A. (2014) · Aging Cell · doi:10.1111/acel.12251 · Cited by 64
“In addition, PPAR-a activation upregulates gene expression of FA2H, CPT, and ACAD8 (Rakhshandehroo et al., 2007; Makowski et al., 2009; Takeda et al., 2013), findings that may explain the associations found between 2-hydroxypalmitate, glutarylcarnitine [reductions in glutarylcarnitine are related…”
BackgroundBaker, P. R., Boyle, K. E., Koves, T. R., Ilkayeva, O., Muoio, D. M., Houmard, J. A., & Friedman, J. E. (2015) · Obesity · doi:10.1002/oby.21046 · Cited by 67
“Skeletal muscle organic acids, including lactate, succinate, fumarate, malate, citrate, and alpha-ketoglutarate (17), were quantified using methods described previously employing Trace Ultra GC coupled to a Trace DSQ MS operating under Excalibur 1.”
MethodSelf-citationMultiparity leads to obesity and inflammation in mothers and obesity in male offspring
Rebholz, S. L., Jones, T., Burke, K. T., Jaeschke, A., Tso, P., D’Alessio, D. A., & Woollett, L. A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2011 · Cited by 67
Grabacka, M., Pierzchalska, M., & Reiss, K. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030009 · Cited by 58
“PPAR α activation and fasting state in mice decrease blood urea levels, which reflect the rate of total aminoacid catabolism [119, 121].”
BackgroundKiermayer, C., Northrup, E., Schrewe, A., Walch, A. K., de Angelis, M. H., Schoensiegel, F., Zischka, H., Prehn, C. P., Adamski, J., Bekeredjian, R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002153 · Cited by 63
“Acyl-carnitines are used as biomarkers for mitochondrial function because they are byproducts of fatty acid, glucose, and AA oxidation and their accumulation indicates deregulated b-oxidation and mitochondrial dysfunction.(56,57) In Txnrd2 / and control hearts, the 2 major carnitines were free carnitine ( 80% and 72%)…”
BackgroundPrevention and reversal of hepatic steatosis with a high-protein diet in mice
Garcia‐Caraballo, S., Comhair, T. M., Verheyen, F., Gaemers, I. C., Schaap, F. G., Houten, S. M., Hakvoort, T. B. M., Dejong, C. H. C., Lamers, W. H., & Köhler, E. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.003 · Cited by 62
Fougerat, A., Bruse, J., Polizzi, A., Montagner, A., Guillou, H., & Wahli, W. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101303 · Cited by 59
“…mice has revealed that the absence of PPAR α leads to decreased plasma levels of alanine and tyrosine, and increased levels of amino acids linked to the urea cycle, suggesting that impaired β -oxidation in the absence of PPAR α results in a compensatory increase of amino acid catabolism [123].”
InfluentialReversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo, H., Kong, W., Zhang, L., Han, J., Clark, L. H., Yin, Y., Fang, Z., Sun, W., Wang, J., Gilliam, T. P., et al. (2019) · PubMed Central · Cited by 59
Self-citationThe Molecular and Metabolic Influence of Long Term Agmatine Consumption
Nissim, I., Horyn, O., Daikhin, Y., Chen, P., Li, C., Wehrli, S. L., Nissim, I., & Yudkoff, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544726 · Cited by 51
“It is well established that chronic HFD feeding or genetically induced diabetes impairs carnitine status (21), possibly due to a disruption of gene activity involved in Car biosynthesis and transport (40).”
BackgroundCappuccio, G., Pinelli, M., Alagia, M., Donti, T., Day-Salvatore, D.-L., Veggiotti, P., GIORGIS, V. D., Lunghi, S., Vari, M. S., Striano, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184022 · Cited by 51
Rodríguez, J. E., Liao, J.-Y., He, J., Schisler, J. C., Newgard, C. B., Drujan, D., Glass, D. J., Frederick, C. B., Yoder, B. C., Lalush, D. S., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.008 · Cited by 50
“To determine the amount of imported and oxidized fatty acids, we performed an acylcarnitine profile analysis to quantify fatty acid oxidation intermediates, an assay established to reflect changes in PPARa activity in vivo (Makowski et al., 2009; Chen et al., 2009; Laghezza et al., 2013; Turer et al., 2009) (Fig.”
Koves, T. R., Zhang, G., Davidson, M. T., Chaves, A., Crown, S. B., Johnson, J. M., Slentz, D. H., Grimsrud, P. A., & Muoio, D. M. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.016 · Cited by 50
Self-citationImpairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice
Cotter, D. G., Erçal, B., d’Avignon, D. A., Dietzen, D. J., & Crawford, P. A. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00087.2014 · Cited by 46
Ahmad, S., Kumar, K. A., Basak, T., Bhardwaj, G., Yadav, D. K., Lalitha, A., Chandak, G. R., Raghunath, M., & Sengupta, S. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.07.027 · Cited by 44
Ectopic lipid deposition and the metabolic profile of skeletal muscle in ovariectomized mice
Jackson, K. C., Wohlers, L. M., Lovering, R. M., Schuh, R. A., Maher, A. C., Bonen, A., Koves, T. R., Ilkayeva, O., Thomson, D. M., Muoio, D. M., et al. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00428.2012 · Cited by 42
“Odd-chain acyl-carnitine species propionylcarnitine (C3), isovalerylcarnitine (C5), and tiglyl carnitine (C5:1) are products of BCAA catabolism (32, 38).”
BackgroundSelf-citationRadler, U., Stangl, H., Lechner, S., Lienbacher, G., Krepp, R., Zeller, E., Brachinger, M., Eller-Berndl, D., Fischer, A., Anzur, C., et al. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000327150 · Cited by 49
“and also PPARα – / – mice had 40–50p lower plasma and tissue levels of free carnitine, corresponding with diminished hepatic expression of genes involved in carnitine biosynthesis and transport. Administration of L -carnitine reverses these effects, probably bypassing the active step in carnitine uptake through the ac…”
BackgroundRingseis, R., Mooren, F., Keller, J., Couturier, A., Wen, G., Hirche, F., Stangl, G. I., Eder, K., & Krüger, K. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100040 · Cited by 43
Wang, X. Q., & Kadarmideen, H. N. (2020) · Metabolites · doi:10.3390/metabo10050201 · Cited by 44
“Previous study 252 indicated that the amount of isovalerylcarnitine could decrease in the plasma and liver tissues but 253 greatly increased in the muscle tissue, as a byproduct of leucine catabolism [41].”
BackgroundRawat, A., Gust, K. A., Deng, Y., García‐Reyero, N., Quinn, M. J., Johnson, M. S., Indest, K. J., Elasri, M. O., & Perkins, E. J. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00022.2010 · Cited by 39
Mechanism for Prevention of Alcohol-Induced Liver Injury by Dietary Methyl Donors
Powell, C. L., Bradford, B. U., Craig, C. P., Tsuchiya, M., Uehara, T., O’Connell, T. M., Pogribny, I. P., Melnyk, S., Koop, D. R., Bleyle, L. A., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq031 · Cited by 40
“(Makowski et al., 2009) demonstrated that Page 17 of 34 Toxicological Sciences”
BackgroundEder, K., & Ringseis, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.042 · Cited by 40
Chambers, K. T., Chen, Z., Crawford, P. A., Fu, X., Burgess, S. C., Lai, L., Leone, T. C., Kelly, D. P., & Finck, B. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052645 · Cited by 42
“This metabolic profile of short-chain acylcarnitine depletion and long-chain acylcarnitine accumulation is consistent with defects in the capacity for fatty acid b-oxidation [29,30].”
BackgroundGong, Y., Geng, N., Zhang, H., Luo, Y., Giesy, J. P., Sun, S., Wu, P., Yu, Z., & Chen, J. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.144957 · Cited by 36
“When fatty acid cannot be broke down efficiently, LC-ACs accumulate in cells whereas amounts of short species and free L-carnitine decrease (Makowski et al., 2009; van VLIES et al., 2005).”
BackgroundAdaptation of Phenylalanine and Tyrosine Catabolic Pathway to Hibernation in Bats
Pan, Y.-H., Zhang, Y., Cui, J., Liu, Y., McAllan, B. M., Liao, C.-C., & Zhang, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062039 · Cited by 35
“This possibility is supported by the transcription factors such as PPARs and HNFs predicted by IPA (Figure 2) that play a role in the regulation of both proteolysis and lipolysis [60,65].”
BackgroundLi, L., Lv, H., Jiang, Z., Qiao, F., Chen, L., Zhang, M., & Du, Z. (2020) · The Journal of Physiology · doi:10.1113/jp279814 · Cited by 35
“…of amino acid metabolism, including the oxidation of α-keto acids, amino acid interconversion and the synthesis of amino acid-derived products in mammals (Leuenberger & Wahli 2010). ppara-deficient mice demonstrate greater amino acid catabolism and urea cycle activity (Makowski et al. 2009).”
BackgroundBjørndal, B., Burri, L., Wergedahl, H., Svardal, A. M., Bohov, P., & Berge, R. K. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0254-8 · Cited by 37
A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis
Guelzim, N., Mariotti, F., Martin, P. G. P., Lasserre, F., Pineau, T., & Hermier, D. (2010) · Amino Acids · doi:10.1007/s00726-010-0797-7 · Cited by 33
“Plasma markers of arginine metabolism (urea, amino acids of the urea cycle) were also affected (Kersten et al. 2001; Makowski et al. 2009; Sheikh et al. 2007), as well as kidney NOS activity (Newaz et al. 2005).”
BackgroundMethodResultInfluentialRingseis, R., Wen, G., & Eder, K. (2012) · PPAR Research · doi:10.1155/2012/868317 · Cited by 39
“[63] is worth mentioning which reported that PPARα knockout mice display markedly lower levels of methionine, which serves as a methyl donor during posttranslational assembly of methylated proteins, and α-ketoglutarate, which is a cofactor of TMLHE and BBOX1, in plasma and tissues, respectively, than wild-type mice.”
BackgroundLi, G., Brocker, C. N., Yan, T., Xie, C., Krausz, K. W., Xiang, R., & Gonzalez, F. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.011 · Cited by 34
“In the fasted state, PPARA deficiency causes an obvious disturbance in fatty acid metabolism as there is a significant decrease and increase in serum short-chain and long-chain acylcarnitines, respectively, which is consistent with a previous report [38].”
BackgroundResultSeifert, E. L., Fiehn, O., Bezaire, V., Bickel, D. R., Wohlgemuth, G., Adams, S. H., & Harper, M.-E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009834 · Cited by 30
“However, beyond the acylcarnitine species [22,25,26,27], the metabolites associated with skeletal muscle mitochondrial FAO are poorly explored.”
BackgroundLindquist, C., Bjørndal, B., Rossmann, C. R., Tusubira, D., Svardal, A. M., Røsland, G. V., Tronstad, K. J., Hallström, S., & Berge, R. K. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074849 · Cited by 27
“In contrast, mRNA levels of Crat and the carnitine transporter, Slc22a5, were increased as a consequence of 1-triple TTA treatment (Fig.”
ResultInfluentialNutrition and Metabolic Correlates of Obesity and Inflammation: Clinical Considerations
Johnson, A. R., & Makowski, L. (2015) · Journal of Nutrition · doi:10.3945/jn.114.200758 · Cited by 30
Self-citationThe therapeutic prospects of using l-carnitine to manage hypertension-related organ damage
Mate, A., Miguel‐Carrasco, J. L., & Vázquez, C. M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.014 · Cited by 29
“R eiew s P O S T S C R E E N 69 Makowski, L. et al. (2009) Metabolic profiling of PPARalpha / mice reveals defects”
BackgroundConsitt, L. A., Koves, T. R., Muoio, D. M., Nakazawa, M., Newton, C. A., & Houmard, J. A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.116 · Cited by 27
Self-citationMa, Y., Zhou, W., Chen, P. L., Urriola, P. E., Shurson, G. C., Ruan, R. R., & Chen, C. (2019) · Nutrients · doi:10.3390/nu11091971 · Cited by 28
“Additionally, the increases of carnitine and short-chain acylcarnitine could also be the consequence of PPARα activation, because both carnitine biosynthesis and transport are positively regulated by PPARα [29], and short-chain acylcarnitines were decreased in PPARα-null mice [30].”
BackgroundHasenour, C. M., Ridley, D. E., James, F. D., Hughey, C. C., Donahue, E. P., Viollet, B., Foretz, M., Young, J. D., & Wasserman, D. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170382 · Cited by 30
Ganguly, S., Finkelstein, D., Shaw, T. I., Michalek, R. D., Zorn, K. M., Ekins, S., Yasuda, K., Fukuda, Y., Schuetz, J. D., Mukherjee, K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253852 · Cited by 25
A High Dose of Isoniazid Disturbs Endobiotic Homeostasis in Mouse Liver
Li, F., Wang, P., Liu, K., Tarragó, M. G., Lu, J. L., Chini, E. N., & Ma, X. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070920 · Cited by 25
“Therefore, the accumulation of oleoyl-L-carnitine and linoleoyl-L-carnitine suggests mitochondrial dysfunction (Makowski et al., 2009; Sampey et al., 2012).”
BackgroundBurniston, J. G., Kenyani, J., Wastling, J. M., Burant, C., Qi, N., Koch, L. G., & Britton, S. L. (2011) · PROTEOMICS · doi:10.1002/pmic.201000593 · Cited by 25
“Interestingly, metabolomic profiling of PPARa / mice [21] reveals a compensatory increase in leucine metabolism.”
BackgroundRingseis, R., & Eder, K. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.016 · Cited by 25
Henagan, T. M. (2014) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2014.00127 · Cited by 27
“Several genetic factors have been implicated in the underlying pathophysiology of obesity and obesity-associated metabolic dysregulation of lipids and insulin resistance [10-12]; yet, the onset and progression of obesity and type 2 diabetes are largely due to environmental factors, such as increased dietary fat conten…”
BackgroundWen, G., Kühne, H., Rauer, C., Ringseis, R., & Eder, K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.006 · Cited by 23
Wen, G., Ringseis, R., Rauer, C., & Eder, K. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.01.004 · Cited by 23
Metabolic profiling of muscle contraction in lean compared with obese rodents
Thyfault, J. P., Cree, M. G., Tapscott, E. B., Bell, J. A., Koves, T. R., Ilkayeva, O., Wolfe, R. R., Dohm, G. L., & Muoio, D. M. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00093.2010 · Cited by 21
Self-citationFiamoncini, J., de Lima, T. M., Hirabara, S. M., Ecker, J., Gorjão, R., Romanatto, T., Elolimy, A. A., Worsch, S., Laumen, H., Bader, B., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400743 · Cited by 21
Hasenour, C. M., Wall, M. L., Ridley, D. E., James, F. D., Hughey, C. C., Donahue, E. P., Viollet, B., Foretz, M., Young, J. D., & Wasserman, D. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183601 · Cited by 18
The Carnitine Transporter Network: Interactions with Drugs
Indiveri, C., Pochini, L., Oppedisano, F., & Tonazzi, A. (2010) · Current Chemical Biology · doi:10.2174/2212796811004020108 · Cited by 20
“Alteration of carnitine homeostasis is associated with several pathologies including cancer and can be caused by xenobiotics [2, 17, 70, 72-74].”
BackgroundBjørndal, B., Brattelid, T., Strand, E., Vigerust, N. F., Svingen, G. F. T., Svardal, A. M., Nygard, O. K., & Berge, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066926 · Cited by 17
“A previous study demonstrated increased amino acid catabolism in mice lacking PPARa [36].”
BackgroundTobón‐Cornejo, S., Vargas‐Castillo, A., Leyva-Martínez, A., Ortíz, V., Noriega, L. G., Velázquez‐Villegas, L. A., Alemán, G., Furosawa-Carballeda, J., Torres, N., & Tovar, A. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154705 · Cited by 17
Zeisel, S. H., Waterland, R. A., Ordovás, J. M., Muoio, D. M., Jia, W. P., & Fodor, A. A. (2012) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607112462401 · Cited by 17
Self-citationHuang, J., Li, J., Ning, Y., Ren, Y., Shao, Y., Zhang, H., Zong, X., & Shi, H. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00712 · Cited by 17
Broderick, T. L., Cusimano, F. A., Carlson, C., & Babu, J. R. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/2785090 · Cited by 14
“Evidence for this essential role of PPARα on carnitine homeostasis was confirmed in hepatocytes overexpressing PPARα and in PPARα-null mice [16], the latter which mice developed carnitine deficiency as a result of decreased hepatic c-BBH and OCTN2 expression [17].”
BackgroundDionne, S., Elimrani, I., Roy, M.-J., Qureshi, I. A., Sarma, D. S. R., Levy, E. H., & Seidman, E. G. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.722247 · Cited by 15
“This concentration corresponds to 150 mg/kg/day, which is the same range as the doses used in other studies (59,60).”
ResultUpadhyay, A., Boyle, K. E., & Broderick, T. L. (2021) · Molecules · doi:10.3390/molecules26226872 · Cited by 11
“Evidence shows that expression of γ-BBH and OCTN2 is dependent on activation of PPAR-α since PPAR-α-null mice exhibit low OCTN2 expression and develop carnitine deficiency [32,43].”
BackgroundIslam, M. N., Mishra, V. K., Munalisa, R., Parveen, F., Ali, S. F., Akter, K., Ahmed, T., Ho, T., & Huang, C. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00424-4 · Cited by 11
Health aspects of oxidized dietary fats
Eder, K., & Ringseis, R. (2010) · Elsevier eBooks · doi:10.1533/9780857090447.1.143 · Cited by 14
Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice
Frankó, A., Irmler, M., Prehn, C. P., Heinzmann, S. S., Schmitt‐Kopplin, P., Adamski, J., Beckers, J., von Kleist-Retzow, J., Wiesner, R. J., Häring, H., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030616 · Cited by 10
“PPARα knock-out mice were characterized by an enhanced gene expression of urea cycle enzymes [58] and increased hepatic fumarate content [59].”
BackgroundThe Current Status of Metabolomics in Drug Discovery and Development
Robertson, D. G., & Reily, M. D. (2012) · Drug Development Research · doi:10.1002/ddr.21047 · Cited by 10
Leng, D., Huang, C., Lei, K. C., Sun, S., Sun, B., & Zhang, X. D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33735 · Cited by 9
“PPAR-induced FA oxidation has previously been associated with increased L-carnitine and acetylcarnitine in plasma[18, 19], and with increased mRNA level of Bbox1 and Slc22a5[18, 20], while in this study, hepatic Bbox1 mRNA, plasma L-carnitine and acetylcarnitine were lowered[21].”
BackgroundHan, J. S., Kim, K., Jung, Y., Lee, J., Namgung, J., Lee, H., Suh, J., Hwang, G., & Lee, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-33058-x · Cited by 10
Age and APOE affect L-carnitine system metabolites in the brain in the APOE-TR model
Huguenard, C. J. C., Cseresznye, A., Darcey, T. S., Nkiliza, A., Evans, J. E., Hazen, S. L., MULLAN, M. J., Crawford, F., & Abdullah, L. I. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1059017 · Cited by 9
“This dose and time regiment was chosen as has been shown to be well-tolerated in mice while producing measurable biological effects on the mitochondria (Makowski et al., 2009; Xia et al., 2011).”
Regulation of Peripheral Metabolism by Substrate Partitioning in the Brain
Moreno, C. L., Yang, L. C., Dacks, P. A., Isoda, F., Poplawski, M. M., & Mobbs, C. V. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.007 · Cited by 8
“For example, replacing Ppar-alpha in the liver of Ppar-alpha knockout mice does not reverse the elevated whole-body glucose metabolism in these mice but activating Ppar-alpha in the brain reduces whole-body glucose metabolism [104].”
BackgroundInfluentialCarneiro, C. L. D. S., da Cruz, T. P., Monteiro, L. C. P., Glugoski, L., Adeshına, İ., Lipinski, L. C., Vicari, M. R., Nogaroto, V., Furuya, V. R. B., Gatlin, D. M., III, et al. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110314 · Cited by 6
Lu, Z., Xu, Z., Shen, Z., Shen, H., & Aschenbach, J. R. (2019) · BMC Genomics · doi:10.1186/s12864-019-6233-9 · Cited by 6
“PPAR, specifically hepatic PPARα, signaling is known to suppress the expressions of genes encoding for AA metabolism and ureagenesis [27, 28].”
BackgroundLeucine Supplementation Ameliorates Early-Life Programming of Obesity in Rats
Sun, Y., Sun, B., Han, X., Shan, A., & Ma, Q. (2023) · Diabetes · doi:10.2337/db22-0862 · Cited by 5
Staff, T. P. B. (2018) · PLoS Biology · doi:10.1371/journal.pbio.3000035 · Cited by 4
Kontoh-Twumasi, R., Aliste, A., Scheid, A., Lax, K., Glass, J., Sharma, A., & Sharma, S. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.39 · Cited by 2
“Given that peroxisome proliferator-activated receptor alpha (PPAR α ) is a key regulator of mitochondrial fatty acid β -oxidation and lipid homeostasis, 28,29 we next examined whether its expression was altered by hyperosmolar stress and L-carnitine treatment.”
Piovezan, M. (2014) · Journal of Food & Nutritional Disorders · doi:10.4172/2324-9323.1000149 · Cited by 3
“A specific accumulation of saturated acylcarnitines was found in plasma of rats fed the cafeteria diet, indicating inefficient betaoxidation [41,42], which together with the abundance of these fatty acids in the diet would contribute to their higher concentrations in plasma.”
Background
Metadata
- Authors
- Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., & Muoio, D. M.
- Affiliations
- Duke University (US)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-10-22
- Volume
- 23
- Issue
- 2
- Pages
- 586-604
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2630792
- OpenAlex
- W2062936856
- Cited by
- 113
- References
- 71
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P30‐AG028716, K99‐AA017376‐01, F32‐DK080609)
- American Diabetes Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- PPARα, L-carnitine, acylcarnitines, carnitine palmitoyltransferase 1, fatty acid beta-oxidation, fat oxidation, amino acid homeostasis, urea cycle, TCA cycle, carnitine biosynthesis, carnitine supplementation, fasting, metabolite profiling, PPARα knockout mice
- MeSH terms
- Acylation, Administration, Oral, Amino Acids, Animals, Animal Feed, Carnitine, Hot Temperature, Homeostasis, Male, Mice, Knockout, Muscle, Skeletal, PPAR alpha, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.